Erythema multiforme
Showing 1 - 25 of 1,423
Erythema Multiforme Trial in Philadelphia (Apremilast)
Recruiting
- Erythema Multiforme
-
Philadelphia, PennsylvaniaPerelman Center For Advanced Medicine
May 16, 2023
Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
Recruiting
- Stevens-Johnson Syndrome
- +7 more
-
Créteil, FranceHenri Mondor
May 2, 2022
Plaque Psoriasis Trial in Fort Gratiot (Clobex Spray)
Completed
- Plaque Psoriasis
- Clobex Spray
-
Fort Gratiot, MichiganHamzavi Dermatology
Sep 7, 2022
Prostate Biopsies With Target Lesion on MRI
Completed
- Prostate Cancer
-
Montpellier, FranceUniversity hospital
Dec 31, 2020
Plaque Psoriasis Trial in Louisville (Enstilar)
Completed
- Plaque Psoriasis
-
Louisville, KentuckyDermResearch, PLLC
Aug 25, 2020
Prostate Cancer, Magnetic Resonance Imaging, Target Lesion Trial in Galveston (MRI/ultrasound transperineal prostate biopsy,
Completed
- Prostate Cancer
- +5 more
- MRI/ultrasound transperineal prostate biopsy
- transrectal ultrasound-guided prostate biopsy
-
Galveston, TexasThe University of Texas Medical Branch at Galveston
May 22, 2019
Health, Subjective Trial in Seoul (BMI2004, 0.9% NaCl)
Completed
- Health, Subjective
- BMI2004
- 0.9% NaCl
-
Seoul, Heukseok-ro, Dongjak-gu, Korea, Republic ofChung-Ang University Hospital
Jun 26, 2023
Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,
Terminated
- Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
- Chemotherapy with Temodar.
- Radiation therapy
-
Baltimore, MarylandUmmc Msgcc
Dec 1, 2022
Ependymoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))
Terminated
- Ependymoma
- Antineoplaston therapy (Atengenal + Astugenal)
-
Houston, TexasBurzynski Clinic
Feb 18, 2022
Acne Vulgaris Trial in Zagazig (Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser)
Recruiting
- Acne Vulgaris
- Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser
-
Zagazig, Al Sharqia, EgyptReham Essam
Nov 12, 2022
Hypercholesterolemia Trial (Ezetimibe, atorvastatin)
Completed
- Hypercholesterolemia
- (no location specified)
Feb 7, 2022
Patient With Facial Erythema Trial in Assiut (Tranexamic Acid 500 MG)
Completed
- Patient With Facial Erythema
- Tranexamic Acid 500 MG
-
Assiut, EgyptAzhar University
Jun 9, 2023
Photoaging Trial (Oral herbal supplement, Oral supplement)
Not yet recruiting
- Photoaging
- Oral herbal supplement
- Oral placebo supplement
- (no location specified)
Nov 17, 2023
Brain and CNS Tumors, Glioblastoma Multiforme Trial in United States (Celecoxib, Isotretinoin, Temozolomide)
Completed
- Brain and Central Nervous System Tumors
- Glioblastoma Multiforme
- Celecoxib
- +3 more
-
Fort Smith, Arkansas
- +11 more
Sep 21, 2021
Rosacea, Papulopustular Rosacea Trial in Washington (drug, device, other)
Completed
- Rosacea
- Papulopustular Rosacea
- Aminolevulinic acid topical solution 20%
- +2 more
-
Washington, District of ColumbiaMedical Faculty Associates - George Washington University
Dec 1, 2022
CLABSI - Central Line Associated Bloodstream Infection, CRBSI - Catheter Related Bloodstream Infection, Digital Technology Trial
Completed
- CLABSI - Central Line Associated Bloodstream Infection
- +2 more
- Set of Photos
-
Vienna, AustriaDepartment of Anesthesia, General Intensive Care and Pain Manage
Oct 14, 2022
Netherton Syndrome Trial in Paris (DS-2325a, Placebo)
Not yet recruiting
- Netherton Syndrome
- DS-2325a
- Placebo
-
Paris, FranceSaint Louis Hospital
Jul 31, 2023
A Close Examination of Patient Experiences in Glioblastoma
Not yet recruiting
- Glioblastoma Multiforme
-
San Francisco, CaliforniaPower Life Sciences
Jul 14, 2023
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Acne Vulgaris, Post Inflammatory Hyperpigmentation, Post Inflammatory Pigmentation Change Trial in Boston (Tazarotene 0.045%
Completed
- Acne Vulgaris
- +4 more
- Tazarotene 0.045% Lotion
-
Boston, MassachusettsThe Dermatology Institute of Boston
Jan 19, 2023
Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)
Terminated
- Leukemia
- Brentuximab Vedotin
- 5-Azacytidine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 7, 2022
Healthy Trial in Detroit (Light Source B: Visible Light solar simulator (VL + UVA1), Light Source A: Visible Light solar
Recruiting
- Healthy
- Light Source B: Visible Light solar simulator (VL + UVA1)
- Light Source A: Visible Light solar simulator closer match to sunlight (VL +UVA1)
-
Detroit, MichiganHenry Ford Medical Center
Jul 25, 2023
Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)
Recruiting
- Glioblastoma Multiforme
- BEY1107
- Temozolomide
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 13, 2023
Eyelid Erythema Trial in Boston (Tegaderm Eye Tape, Transpore Eye Tape)
Recruiting
- Eyelid Erythema
- Tegaderm Eye Tape
- Transpore Eye Tape
-
Boston, MassachusettsTufts Medical Center
Apr 26, 2022